SYNERGIC COMBINATION OF H2-RECEPTOR INHIBITORS, INERT SILICONE AND A HYDROXYMAGNESIUM ALUMINATE COMPLEX

摘要

The present invention relates to the pharmaceutical industry in general and to the pharmaceutical industry that prepares medicinal products for the prevention and/or treatment of peptic acid disorders and symptoms related to the excess production of gastric acid, in addition to contributing to cicatrization and the prevention of recurrences of symptoms and complications, in particular. It has advantages as compared with prior-art compositions, such as a smaller dose of each element to prevent or substantially to reduce the secondary effects and a therapeutic effect at least equal to the effects of prior-art compositions. This composition is characterized in that it comprises a type-2 histamine-receptor-inhibiting agent, an antiflatulence agent, an antacid, and also pharmaceutically acceptable excipients.